Megan Rianne Wolf, MD | |
863 N Main Street Ext Ste 200, Wallingford, CT 06492-2434 | |
(203) 265-3280 | |
Not Available |
Full Name | Megan Rianne Wolf |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 863 N Main Street Ext Ste 200, Wallingford, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861803538 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Megan Rianne Wolf, MD 863 N Main Street Ext Ste 200, Wallingford, CT 06492-2434 Ph: (203) 265-3280 | Megan Rianne Wolf, MD 863 N Main Street Ext Ste 200, Wallingford, CT 06492-2434 Ph: (203) 265-3280 |
News Archive
Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.
Metabolic complications of obesity and overweight, such as type 2 diabetes, are an important challenge to public health. Teams led by Nicolas Venteclef, Inserm Research Fellow (Cordeliers Research Centre, Inserm/Pierre and Marie Curie University Joint Research Unit 1138, Paris, France) and Irina Udalova (Kennedy Institute of Rheumatology, University of Oxford, UK) in collaboration with several teams, have succeeded in elucidating part of the mechanisms involved in the development of these metabolic complications associated with obesity.
New research findings published in the May issue of the Journal of the American College of Surgeons indicate that delaying cholecystectomy, the surgical removal of the gallbladder, in elderly patients with sudden inflammation of the organ often results in increased costs, morbidity and mortality.
Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis, kidney fibrosis, and other indications using Bone Morphogenetic Protein (BMP)-7, announced today initial results from the Phase II(a) trial of local BMP-7 administration in patients with moderate osteoarthritis of the knee.
› Verified 5 days ago
Dr. Hudson Seidel, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 863 N Main Street Ext Ste 200, Wallingford, CT 06492 Phone: 203-265-3280 Fax: 203-741-6569 | |
Dr. Adam Quinn Ferguson, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 863 N Main Street Ext Ste 200, Wallingford, CT 06492 Phone: 203-265-3280 | |
Dr. Aaron Saul Covey, MD, MBA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 863 N Main Street Ext, Suite 200, Wallingford, CT 06492 Phone: 203-265-3280 Fax: 203-741-6569 | |
Ronald S Paret, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 863 N Main Street Ext, Suite 200, Wallingford, CT 06492 Phone: 203-265-3280 Fax: 203-741-6575 | |
Leonard A Kolstad, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 863 N Main Street Ext, Suite 200, Wallingford, CT 06492 Phone: 203-265-3280 Fax: 203-741-6569 | |
Dr. Jon C Driscoll, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 863 N Main Street Ext, Suite 200, Wallingford, CT 06492 Phone: 203-265-3280 Fax: 203-741-6575 | |
Ryan S Charette, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 863 North Main Street, Extension, Suite 200, 2nd Floor, Wallingford, CT 06492 Phone: 203-265-3280 |